Related references
Note: Only part of the references are listed.Partition-Defective 3 (PARD3) Regulates Proliferation, Apoptosis, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells
Lei Wang et al.
MEDICAL SCIENCE MONITOR (2017)
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group
Michael Luebbert et al.
ANNALS OF HEMATOLOGY (2016)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials
Seongseok Yun et al.
CLINICAL EPIGENETICS (2016)
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
Jeannine Diesch et al.
CLINICAL EPIGENETICS (2016)
DNA demethylation and invasive cancer: implications for therapeutics
David Cheishvili et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
Ontogeny, conservation and functional significance of maternally inherited DNA methylation at two classes of non-imprinted genes
Charlotte E. Rutledge et al.
DEVELOPMENT (2014)
5-Hydroxymethylation marks a class of neuronal gene regulated by intragenic methylcytosine levels
Rachelle E. Irwin et al.
GENOMICS (2014)
Characterizing DNA methylation alterations from The Cancer Genome Atlas
Daniel J. Weisenberger
JOURNAL OF CLINICAL INVESTIGATION (2014)
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
F. Traina et al.
LEUKEMIA (2014)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
USP33, a new player in lung cancer, mediates Slit-Robo signaling
Pushuai Wen et al.
PROTEIN & CELL (2014)
Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis
Michael E. Feigin
FEBS JOURNAL (2013)
DNA methylation: roles in mammalian development
Zachary D. Smith et al.
NATURE REVIEWS GENETICS (2013)
Functional DNA demethylation is accompanied by chromatin accessibility
Kurinji Pandiyan et al.
NUCLEIC ACIDS RESEARCH (2013)
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Hanne Fredly et al.
CLINICAL EPIGENETICS (2013)
DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies
Jacques Fahy et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Marta Kulis et al.
NATURE GENETICS (2012)
De novo DNA methylation: a germ cell perspective
Sebastien A. Smallwood et al.
TRENDS IN GENETICS (2012)
High density DNA methylation array with single CpG site resolution
Marina Bibikova et al.
GENOMICS (2011)
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing
Sanjeev Shukla et al.
NATURE (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Epigenetics in acute myeloid leukemia
Christoph Plass et al.
SEMINARS IN ONCOLOGY (2008)
5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3K9 di-methylation levels are linked to tumor suppressor gene reactivation
R. J. Wozniak et al.
ONCOGENE (2007)
Valproic acid malignancies for the treatment of myeloid
Andrea Kuendgen et al.
CANCER (2007)
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
Guillermo Garcia-Manero et al.
BLOOD (2006)
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
SD Gore et al.
CANCER RESEARCH (2006)
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal
K Ghoshal et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
FDA drug approval summary:: Azacitidine (5-azacytidine, Vidaza™) for injectable suspension
E Kaminskas et al.
ONCOLOGIST (2005)
Enhancement of antineoplastic action of 5-aza-2 '-deoxycytidine by phenylbutyrate on L1210 leukemic cells
M Lemaire et al.
LEUKEMIA & LYMPHOMA (2004)
PANTHER: A library of protein families and subfamilies indexed by function
PD Thomas et al.
GENOME RESEARCH (2003)
Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases
L Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
V Santini et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
